News Detail
Sweden, 7 Feb 2023: The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows. Patients receiving the drug include those with moderate to severe psoriasis; but in this p......
View Details
Source : News Medical Net
Arthritis
Basal Cell Carcinoma
Cancer
Carcinoma
Cell
Dermatology
Drugs
Epidemiology
Health Care
Hospital
Kidney
Kidney Disease
Light Therapy
Liver
Malignant
Medicine
Melanoma
Methotrexate
Psoriasis
Research
Rheumatoid Arthritis
Rheumatology
Skin
Skin Cancer
Squamous Cell Carcinoma
Related News
- Geometric machine learning method promises to accelerate precision drug development (20-01-2025)
- AI-Designed Antivenom Counteracts Toxins from Snakebites (17-01-2025)
- Researchers develop Quantum Dots that can help detect Antibiotics (17-01-2025)
- Feeding your good gut bacteria through fibre in diet may boost body against infections (13-01-2025)
- New combination drug offers treatment against intestinal worms: Lancet (13-01-2025)
- Researchers bypass the liver, delivering genetic drugs to the target location (01-01-2025)
- Study uses AI to cast light on harmful drug-drug interactions (16-12-2024)
- IIT-BHU developing med device with potential to cure sclerosis (28-11-2024)
- Three widely used BP medicines Combo, five times more effective than current drugs (19-11-2024)
- More than half of patients with rheumatic, musculoskeletal disease use OTC supplements: Study (18-11-2024)